Der er rapporteret at små (< 2 år) EBV- VCA- negative børn har en øget risiko for at udvikle lymfoproliferative lidelser.
Very young (< 2 years), EBV-VCA-negative children have been reported to have an increased risk of developing lymphoproliferative disorders.